(Q43089850)
Statements
1 reference
Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial (English)
1 reference
A Colao
1 reference
S Petersenn
1 reference
J Schopohl
1 reference
A Barkan
1 reference
P Mohideen
1 reference
R Abs
1 reference
A Buchelt
1 reference
Y-Y Ho
1 reference
K Hu
1 reference
A J Farrall
1 reference
S Melmed
1 reference
B M K Biller
1 reference
Pasireotide Acromegaly Study Group
1 reference
21 April 2010
1 reference
1 reference
95
1 reference
6
1 reference
2781-2789
1 reference
Identifiers
1 reference
1 reference